Patents by Inventor Christina Louws

Christina Louws has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOSITIONS COMPRISING AN INTERLEUKIN CONSTRUCT
    Publication number: 20210261639
    Abstract: The invention is concerned with a fusion protein, a nucleic acid molecule encoding such fusion protein, a vector comprising such nucleic acid molecule, and a host cell comprising such nucleic acid molecule or such vector. The invention further pertains to a method for producing such fusion protein. The fusion protein or a gene therapy vector encoding the fusion protein may be used in the prevention or treatment of osteoarthritis, chronic pain, a condition characterized by local or systemic inflammation, immune activation, and/or lymphoproliferation.
    Type: Application
    Filed: March 4, 2021
    Publication date: August 26, 2021
    Inventors: Joel Adrianus Gijsbert Van Roon, Sarita Aimee Yvonne Hartgring, Cornelis Erik Hack, Christina Louws, Floris Paulus Jacobus Gerardus Lafeber
  • Fusion protein comprising IL-4 and IL-10
    Patent number: 10981964
    Abstract: The invention is concerned with a fusion protein, a nucleic acid molecule encoding such fusion protein, a vector comprising such nucleic acid molecule, and a host cell comprising such nucleic acid molecule or such vector. The invention further pertains to a method for producing such fusion protein. The fusion protein or a gene therapy vector encoding the fusion protein may be used in the prevention or treatment of osteoarthritis, chronic pain, a condition characterized by local or systemic inflammation, immune activation, and/or lymphoproliferation.
    Type: Grant
    Filed: December 9, 2019
    Date of Patent: April 20, 2021
    Assignee: Synerkine Pharma B.V.
    Inventors: Joel Adrianus Gijsbert Van Roon, Sarita Aimee Yvonne Hartgring, Cornelis Erik Hack, Christina Louws, Floris Paulus Jacobus Gerardus Lafeber
  • Methods of treatment with a fusion protein comprising IL-4 and IL-10
    Patent number: 10851143
    Abstract: The invention is concerned with a fusion protein comprising interleukin 10 and interleukin 4, a nucleic acid molecule encoding such fusion protein, a vector comprising such nucleic acid molecule, and a host cell comprising such nucleic acid molecule or such vector. The invention further pertains to a method for producing such fusion protein. The fusion protein or a gene therapy vector encoding the fusion protein may be used in the prevention or treatment of osteoarthritis, chronic pain, a condition characterized by local or systemic inflammation, immune activation, and/or lymphoproliferation.
    Type: Grant
    Filed: December 14, 2017
    Date of Patent: December 1, 2020
    Assignee: Synerkine Pharma B.V.
    Inventors: Joel Adrianus Gijsbert Van Roon, Sarita Aimee Yvonne Hartgring, Cornelis Erik Hack, Christina Louws, Floris Paulus Jacobus Gerardus Lafeber
  • COMPOSITIONS COMPRISING AN INTERLEUKIN CONSTRUCT
    Publication number: 20200147178
    Abstract: The invention is concerned with a fusion protein, a nucleic acid molecule encoding such fusion protein, a vector comprising such nucleic acid molecule, and a host cell comprising such nucleic acid molecule or such vector. The invention further pertains to a method for producing such fusion protein. The fusion protein or a gene therapy vector encoding the fusion protein may be used in the prevention or treatment of osteoarthritis, chronic pain, a condition characterized by local or systemic inflammation, immune activation, and/or lymphoproliferation.
    Type: Application
    Filed: December 9, 2019
    Publication date: May 14, 2020
    Inventors: Joel Adrianus Gijsbert Van Roon, Sarita Aimee Yvonne Hartgring, Cornelis Erik Hack, Christina Louws, Floris Paulus Jacobus Gerardus Lafeber
  • FUSION PROTEIN COMPRISING AN INTERLEUKIN 4 AND INTERLEUKIN 10
    Publication number: 20180094037
    Abstract: The invention is concerned with a fusion protein comprising interleukin 10 and interleukin 4, a nucleic acid molecule encoding such fusion protein, a vector comprising such nucleic acid molecule, and a host cell comprising such nucleic acid molecule or such vector. The invention further pertains to a method for producing such fusion protein. The fusion protein or a gene therapy vector encoding the fusion protein may be used in the prevention or treatment of osteoarthritis, chronic pain, a condition characterized by local or systemic inflammation, immune activation, and/or lymphoproliferation.
    Type: Application
    Filed: December 14, 2017
    Publication date: April 5, 2018
    Applicant: UMC Utrecht Holding B.V.
    Inventors: Joel Adrianus Gijsbert VAN ROON, Sarita Aimee Yvonne HARTGRING, Cornelis Erik HACK, Christina LOUWS, Floris Paulus Jacobus Gerardus LAFEBER
  • FUSION PROTEIN COMPRISING AN INTERLEUKIN 4 AND INTERLEUKIN
    Publication number: 20140314712
    Abstract: The invention is concerned with a fusion protein comprising interleukin 10 and interleukin 4, a nucleic acid molecule encoding such fusion protein, a vector comprising such nucleic acid molecule, and a host cell comprising such nucleic acid molecule or such vector. The invention further pertains to a method for producing such fusion protein. The fusion protein or a gene therapy vector encoding the fusion protein may be used in the prevention or treatment of osteoarthritis, chronic pain, a condition characterized by local or systemic inflammation, immune activation, and/or lymphoproliferation.
    Type: Application
    Filed: November 8, 2012
    Publication date: October 23, 2014
    Inventors: Joel Adrianus Gijsbert Van Roon, Sarita Aimee Yvonne Hartgring, Cornelis Erik Hack, Christina Louws, Floris Paulus Jacobus Gerardus Lafeber